Comparative Pharmacology
Head-to-head clinical analysis: DIENESTROL versus ESTINYL.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DIENESTROL versus ESTINYL.
DIENESTROL vs ESTINYL
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Synthetic nonsteroidal estrogen that binds to estrogen receptors, activating transcription of estrogen-responsive genes, leading to effects similar to endogenous estrogens.
Estinyl (ethinyl estradiol) is a synthetic estrogen that binds to estrogen receptors, leading to increased synthesis of DNA, RNA, and various proteins in target tissues. It suppresses gonadotropin release, modulating the hypothalamic-pituitary-ovarian axis.
0.1 to 0.5 mg orally once daily for estrogen replacement therapy; 0.5 to 1.0 mg orally once daily for prostatic carcinoma.
0.01-0.05 mg orally once daily for contraception or 2.5-10 mg orally 3-4 times daily for 5-10 days for hemostasis in dysfunctional uterine bleeding. Route: oral. Frequency: daily for contraception; multiple daily doses for acute bleeding.
None Documented
None Documented
Clinical Note
moderateDienestrol + Etoricoxib
"Dienestrol may increase the thrombogenic activities of Etoricoxib."
Clinical Note
moderateDienestrol + Parecoxib
"Dienestrol may increase the thrombogenic activities of Parecoxib."
Clinical Note
moderateDienestrol + Voriconazole
"The metabolism of Voriconazole can be decreased when combined with Dienestrol."
Clinical Note
moderateDienestrol + Lumiracoxib
"Dienestrol may increase the thrombogenic activities of Lumiracoxib."
Terminal elimination half-life is approximately 24-48 hours, longer with hepatic impairment.
Terminal elimination half-life is approximately 13-27 hours (mean ~17 hours); enterohepatic recirculation contributes to variability; steady-state achieved within 3-5 days.
Primarily renal (40-60% as glucuronide conjugates) and biliary/fecal (30-50% with enterohepatic recycling).
Renal excretion of metabolites (approximately 40-50% as ethinyl estradiol glucuronide and sulfate conjugates) and fecal excretion (approximately 20-30% as conjugates and minor metabolites); <10% excreted unchanged in urine.
Category C
Category C
Estrogen
Estrogen